We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science can do. We are science and innovation-led and have a diversified portfolio of medicines across primary, specialty care and rare diseases. We are focused on leading in the therapy areas where we believe we can make the most meaningful difference to patients: Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism and Respiratory & Immunology); and Rare Disease.
Evidence generation through real-world data is a core component of our approach to ensuring that we can demonstrate value to our innovative medicines. We wish to develop and agree to innovative research proposals that can help us achieve the true potential of the DHDP platform particularly for precision medicine in Oncology. We can provide expertise in the review and design of proposals, and potentially collaborate/fund truly differentiated projects.